BioNTech SE (BNTX) Times Interest Earned (2018 - 2025)
BioNTech SE's (BNTX) quarterly Times Interest Earned came in at $76.86 in Q4 2025, up 751.68% year-on-year from $9.02 in Q4 2024, and up 4029.64% quarter-over-quarter from $1.86 in Q3 2025.
BioNTech SE (BNTX) Times Interest Earned (2018 - 2025) Analysis & Trends
BioNTech SE has disclosed Times Interest Earned across 8 years of filings, most recently posting $76.86 for Q4 2025.
- Times Interest Earned for Q4 2025 came in at $76.86, up 751.68% year-over-year; the trailing twelve-month figure through Dec 2025 was $20.01 (down 50.41% YoY), and the FY2025 annual result was $20.13, down 58.04% from the prior year.
- Times Interest Earned came in at $76.86 for Q4 2025 at BioNTech SE, up from $1.86 in the prior quarter.
- In the past five years, Times Interest Earned ranged from a high of $37.2 million in Q1 2021 to a low of -$2238.0 in Q4 2021.
- The 5-year median for Times Interest Earned is -$6.55 (2024), against an average of $1.9 million.
- Across the five-year window, Times Interest Earned soared 6270872.74% in 2021 and tumbled 1693.41% in 2022, its largest moves.
- BioNTech SE's Times Interest Earned stood at -$2238.0 in 2021, then jumped by 99.08% to -$20.7 in 2022, then dropped by 0.89% to -$20.88 in 2023, then surged by 43.52% to -$11.79 in 2024, then jumped by 751.68% to $76.86 in 2025.
- The last three Times Interest Earned figures came in at $76.86 (Q4 2025), $1.86 (Q3 2025), and $71.59 (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 3.58 |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 11.50 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -258.33 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 547.67 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 11.79 |
| 10 | BioNTech SE | 27.38 Bn | 10.07 Bn | 668.28 Mn | 76.86 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 76.86 |
| Sep 30, 2025 | 1.86 |
| Jun 30, 2025 | 71.59 |
| Mar 31, 2025 | 15.76 |
| Dec 31, 2024 | -11.79 |
| Sep 30, 2024 | -1.31 |
| Jun 30, 2024 | 132.36 |
| Mar 31, 2024 | 107.91 |
| Dec 31, 2023 | -20.88 |
| Sep 30, 2023 | -36.55 |
| Jun 30, 2023 | 433.31 |
| Mar 31, 2023 | -22.57 |
| Dec 31, 2022 | -20.70 |
| Sep 30, 2022 | -555.23 |
| Jun 30, 2022 | -380.97 |
| Mar 31, 2022 | -709.36 |
| Dec 31, 2021 | -2,237.95 |
| Sep 30, 2021 | -57.12 |
| Jun 30, 2021 | 23.91 |
| Mar 31, 2021 | 37.19 Mn |